Oxidative stress stimulates the synthesis of the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid by inflammatory cells - PubMed (original) (raw)
. 2004 Sep 24;279(39):40376-84.
doi: 10.1074/jbc.M401294200. Epub 2004 Jul 2.
Affiliations
- PMID: 15234979
- DOI: 10.1074/jbc.M401294200
Free article
Oxidative stress stimulates the synthesis of the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid by inflammatory cells
Karl-Rudolf Erlemann et al. J Biol Chem. 2004.
Free article
Abstract
5-Oxo-ETE (5-oxo-6,8,11,14-eicosatetraenoic acid) is a highly potent granulocyte chemoattractant that acts through a selective G-protein coupled receptor. It is formed by oxidation of the 5-lipoxygenase product 5-HETE (5S-hydroxy-6,8,11,14-eicosatetraenoic acid) by 5-hydroxyeicosanoid dehydrogenase (5-HEDH). Although leukocytes and platelets display high microsomal 5-HEDH activity, unstimulated intact cells do not convert 5-HETE to appreciable amounts of 5-oxo-ETE. To attempt to resolve this dilemma we explored the possibility that 5-oxo-ETE synthesis could be enhanced by oxidative stress. We found that hydrogen peroxide and t-butyl hydroperoxide strongly stimulate 5-oxo-ETE formation by U937 monocytic cells. This was dependent on the GSH redox cycle, as it was blocked by depletion of GSH or inhibition of glutathione reductase and mimicked by oxidation of GSH to GSSG by diamide. Glucose inhibited the response to H2O2 through its metabolism by the pentose phosphate pathway, as its effect was reversed by the glucose-6-phosphate dehydrogenase inhibitor dehydroepiandrosterone. 5-Oxo-ETE synthesis was also strongly stimulated by hydroperoxides in blood monocytes, lymphocytes, and platelets, but not neutrophils. Unlike monocytic cells, lymphocytes and platelets were resistant to the inhibitory effects of glucose. 5-Oxo-ETE synthesis following incubation of peripheral blood mononuclear cells with arachidonic acid and calcium ionophore was also strongly enhanced by t-butyl hydroperoxide. Oxidative stress could act by depleting NADPH, resulting in the formation NADP+, the cofactor for 5-HEDH. This is opposed by the pentose phosphate pathway, which converts NADP+ back to NADPH. Oxidative stress could be an important mechanism for stimulating 5-oxo-ETE production in inflammation, promoting further infiltration of granulocytes into inflammatory sites.
Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.
Similar articles
- The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.
Powell WS, Rokach J. Powell WS, et al. Prog Lipid Res. 2013 Oct;52(4):651-65. doi: 10.1016/j.plipres.2013.09.001. Epub 2013 Sep 19. Prog Lipid Res. 2013. PMID: 24056189 Free PMC article. Review. - 5-oxo-ETE is a major oxidative stress-induced arachidonate metabolite in B lymphocytes.
Grant GE, Gravel S, Guay J, Patel P, Mazer BD, Rokach J, Powell WS. Grant GE, et al. Free Radic Biol Med. 2011 May 15;50(10):1297-304. doi: 10.1016/j.freeradbiomed.2011.02.010. Epub 2011 Feb 18. Free Radic Biol Med. 2011. PMID: 21334434 - Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE.
Powell WS, Rokach J. Powell WS, et al. Prog Lipid Res. 2005 Mar-May;44(2-3):154-83. doi: 10.1016/j.plipres.2005.04.002. Epub 2005 Apr 20. Prog Lipid Res. 2005. PMID: 15893379 Review. - Metabolism of 5-hydroxy-6,8,11,14-eicosatetraenoic acid by human endothelial cells.
Erlemann KR, Cossette C, Gravel S, Stamatiou PB, Lee GJ, Rokach J, Powell WS. Erlemann KR, et al. Biochem Biophys Res Commun. 2006 Nov 10;350(1):151-6. doi: 10.1016/j.bbrc.2006.09.011. Epub 2006 Sep 12. Biochem Biophys Res Commun. 2006. PMID: 16997273 - Airway epithelial cells synthesize the lipid mediator 5-oxo-ETE in response to oxidative stress.
Erlemann KR, Cossette C, Gravel S, Lesimple A, Lee GJ, Saha G, Rokach J, Powell WS. Erlemann KR, et al. Free Radic Biol Med. 2007 Mar 1;42(5):654-64. doi: 10.1016/j.freeradbiomed.2006.12.006. Epub 2006 Dec 14. Free Radic Biol Med. 2007. PMID: 17291989 Free PMC article.
Cited by
- Targeting the OXE receptor as a potential novel therapy for asthma.
Powell WS, Rokach J. Powell WS, et al. Biochem Pharmacol. 2020 Sep;179:113930. doi: 10.1016/j.bcp.2020.113930. Epub 2020 Mar 30. Biochem Pharmacol. 2020. PMID: 32240653 Free PMC article. Review. - Substrate selectivity of 5-hydroxyeicosanoid dehydrogenase and its inhibition by 5-hydroxy-Delta6-long-chain fatty acids.
Patel P, Cossette C, Anumolu JR, Erlemann KR, Grant GE, Rokach J, Powell WS. Patel P, et al. J Pharmacol Exp Ther. 2009 Apr;329(1):335-41. doi: 10.1124/jpet.108.143453. Epub 2009 Jan 22. J Pharmacol Exp Ther. 2009. PMID: 19164464 Free PMC article. - Targeting the OXE receptor with a selective antagonist inhibits allergen-induced pulmonary inflammation in non-human primates.
Cossette C, Miller LA, Ye Q, Chourey S, Reddy CN, Rokach J, Powell WS. Cossette C, et al. Br J Pharmacol. 2022 Jan;179(2):322-336. doi: 10.1111/bph.15721. Epub 2021 Dec 16. Br J Pharmacol. 2022. PMID: 34766334 Free PMC article. - Structural basis for the activation of PPARgamma by oxidized fatty acids.
Itoh T, Fairall L, Amin K, Inaba Y, Szanto A, Balint BL, Nagy L, Yamamoto K, Schwabe JW. Itoh T, et al. Nat Struct Mol Biol. 2008 Sep;15(9):924-31. doi: 10.1038/nsmb.1474. Nat Struct Mol Biol. 2008. PMID: 19172745 Free PMC article. - Alleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory Drugs.
Kyriakopoulos AM, Nagl M, Baliou S, Zoumpourlis V. Kyriakopoulos AM, et al. Int J Inflam. 2017;2017:9632018. doi: 10.1155/2017/9632018. Epub 2017 May 10. Int J Inflam. 2017. PMID: 28573063 Free PMC article. Review.